Joint Modelling for Death and Quality of Life: Worthy as a Primary Endpoint

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Royalty/Intellectual Property Rights - Copyright to KCCQ, SAQ, and PAQ</li><li>Consultant Fee/Honoraria/Speaker’s Bureau - Bristol-Myers Squibb; Janssen Pharmaceuticals; Terumo Medical Corporation</li><li>Grant Support/Research Contract - Janssen Pharmaceuticals</li></ul>